Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Value of DMSA absolute renal uptake (ARU) in assessment of patients with chronic kidney diseases

Hussein Farghaly, Hatem Nasr, Abdullah Al Qarni and Ahmed Kheder
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 92;
Hussein Farghaly
1Nuclear Medicine Unit-Clinical Oncology Department, Assiut University, Assiut, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hatem Nasr
3Nuclear Medicine Unit, Cairo University, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdullah Al Qarni
2Radiology department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Kheder
2Radiology department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

92

Objectives To determine the accuracy of Tc-99m DMSA ARU to assess the severity of CKD in comparison to Cr-51 EDTA GFR

Methods It is a retrospective study using Cr-51 EDTA GFR, creatinine (creat.) and Tc-99m DMSA scans results of 66 patients (pt.) with CKD. Mean age is 62.8±15.07, 35 male and 31 female. Total (left + right) DMSA ARU was calculated using posterior projection after 3 hrs of DMSA injection. The depth of the kidneys was estimated using Tonnensen method. Stages of CKD were based on GFR values according to KDOQI guidelines. Pt were classified into 3 groups; Group 1: GFR ≥ 60 (13 pt.), Group 2: GFR 30-59 ( 30 pt.) and group 3: GFR < 30 ( 23 pt.). The mean total ARU was compared between groups using ANOVA with post Hoc test. Pearson’s correlation was performed between ARU, GFR and creat. Equation to estimate the GFR from the ARU was generated using regression analysis

Results There was significant differences between the study subgroups as regards the mean ARU (group 1=41.4±10.8, group 2=19.7±5.7, group 3=7.9±4.2; p<0.001) as well as for creat. (group 1=89.1±25.9 , group 2=132.1±39.9, group 3=242.8±109.3) with p values between all groups <0.001 except for creat. between group 1 and group 2 (p=0.072). The GFR for the total study group was better correlated to the ARU than to creat. (r=0.914 vs.r=-0.713). The correlation of GFR in pts with GFR ≥40 ml/min was better with ARU than with creat. (r=0.827 vs. r=-0.423), however in pts with GFR <40 ml/min correlation with GFR was comparable for both ARU and creat. (r=0.716 vs. r=-0.708). The equation for rough GFR estimation from ARU was: GFR =14.11+1.40 ARU.

Conclusions The ARU is well correlated to Cr-51 ETDA GFR and can be considered a useful indicator to detect renal impairment specially in early stages of CKD during which serum creatinine is not well correlated to GFR values.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Value of DMSA absolute renal uptake (ARU) in assessment of patients with chronic kidney diseases
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Value of DMSA absolute renal uptake (ARU) in assessment of patients with chronic kidney diseases
Hussein Farghaly, Hatem Nasr, Abdullah Al Qarni, Ahmed Kheder
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 92;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Value of DMSA absolute renal uptake (ARU) in assessment of patients with chronic kidney diseases
Hussein Farghaly, Hatem Nasr, Abdullah Al Qarni, Ahmed Kheder
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 92;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Exploring variations and utility of FDG- and NaF PET/CT in rheumatoid arthritis and osteoarthritis
  • Application of Lung perfusion only scan combined with SPECT/CT for the post-treatment evaluation of massive and sub-massive pulmonary embolism in the age of covid-19 pandemic: case presentation and literature review
  • Can FDG PET/CT imaging have a role in clinical cases of Dermatomyositis?
Show more General Clinical Specialties

Nephrourology

  • Molecular imaging identifies inflammatory cytokine-mediated alterations in renal tubular excretion in vivo
  • Can 18F- FDG replace 67Ga for differentiating acute interstitial nephritis from acute tubular necrosis?
Show more Nephrourology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire